Episurf Medical takes the next step in the UK market by the appointment of Ideal Med Ltd as agent
Episurf Medical (Nasdaq: EPIS B) today announces that the company has entered into a Commercial Agency agreement with Ideal Med Ltd for the sale and distribution of the Episealer® Knee and Episealer® Talus technologies for the UK market. Ideal Med, who will act as an agent for Episurf Medical in the UK market, is a manufacturer and distributor of medical technology products, with a focus on patient-specific innovative solutions. Ideal Med’s sales force covers the entire UK. Episurf Medical is currently allocating additional resources to its Indirect Channel Management strategy, and the